1. Home
  2. ALKS vs LFUS Comparison

ALKS vs LFUS Comparison

Compare ALKS & LFUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALKS
  • LFUS
  • Stock Information
  • Founded
  • ALKS 1987
  • LFUS 1927
  • Country
  • ALKS Ireland
  • LFUS United States
  • Employees
  • ALKS N/A
  • LFUS N/A
  • Industry
  • ALKS Biotechnology: Pharmaceutical Preparations
  • LFUS Electrical Products
  • Sector
  • ALKS Health Care
  • LFUS Energy
  • Exchange
  • ALKS Nasdaq
  • LFUS Nasdaq
  • Market Cap
  • ALKS 5.1B
  • LFUS 4.4B
  • IPO Year
  • ALKS 1991
  • LFUS N/A
  • Fundamental
  • Price
  • ALKS $29.05
  • LFUS $231.21
  • Analyst Decision
  • ALKS Buy
  • LFUS Buy
  • Analyst Count
  • ALKS 12
  • LFUS 5
  • Target Price
  • ALKS $40.00
  • LFUS $252.25
  • AVG Volume (30 Days)
  • ALKS 1.7M
  • LFUS 169.1K
  • Earning Date
  • ALKS 07-23-2025
  • LFUS 07-29-2025
  • Dividend Yield
  • ALKS N/A
  • LFUS 1.20%
  • EPS Growth
  • ALKS N/A
  • LFUS N/A
  • EPS
  • ALKS 2.09
  • LFUS 3.81
  • Revenue
  • ALKS $1,513,770,000.00
  • LFUS $2,209,690,000.00
  • Revenue This Year
  • ALKS N/A
  • LFUS $6.40
  • Revenue Next Year
  • ALKS $4.25
  • LFUS $7.76
  • P/E Ratio
  • ALKS $13.86
  • LFUS $61.19
  • Revenue Growth
  • ALKS N/A
  • LFUS N/A
  • 52 Week Low
  • ALKS $22.90
  • LFUS $142.10
  • 52 Week High
  • ALKS $36.45
  • LFUS $275.58
  • Technical
  • Relative Strength Index (RSI)
  • ALKS 40.26
  • LFUS 65.05
  • Support Level
  • ALKS $29.26
  • LFUS $220.16
  • Resistance Level
  • ALKS $29.53
  • LFUS $228.51
  • Average True Range (ATR)
  • ALKS 0.69
  • LFUS 6.11
  • MACD
  • ALKS -0.14
  • LFUS 0.07
  • Stochastic Oscillator
  • ALKS 14.74
  • LFUS 76.57

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

About LFUS Littelfuse Inc.

Littelfuse is a primary provider of circuit protection products (such as fuses and relays) into the transportation, industrial, telecommunications, and consumer electronics end markets. The firm is also increasing its power semiconductor business, where it predominantly serves industrial end markets and is breaking into electric vehicle charging infrastructure. Littelfuse has 17,000 global employees.

Share on Social Networks: